Health Care Equipment & Services

Sell‑to‑cover sale at Vicarious Surgical shows tax‑cover trades and cash burn concerns, but still offers upside potential for long‑term investors.

Axogen CFO’s net purchase of 10,796 shares signals confidence amid a volatile market, highlighting potential upside from its nerve‑graft tech pipeline.

Insider buying at Bausch + Lomb signals confidence in its high‑growth eye‑care segment—reveals why senior executives are betting on future value.

Ronda Stryker’s recent sale of 55,600 shares hints at insider confidence shifts, yet her 2.23 million‑share stake keeps her voice strong in Stryker Corp.

Insightful analysis of CFO Brian Pooff’s recent insider trading at Addus HomeCare, showing confidence in growth amid industry consolidation and tax‑planning strategy.

Insider buying of Guardant Health shares shows confidence amid volatility: a strategic 264‑share purchase at $94.70 hints at upside potential as analysts lift targets, but earnings gaps warn of gradual growth.

Insider share moves show Medline’s core owner keeps control while others rebalance; high PE, steady gains—watch for future capital actions.

Insider selling at Ceribell may signal confidence shifts, yet AI‑driven EEG tech could still spark a rebound—watch the next Form 4 filings for clues.

Insulet CEO Ashley McEvoy buys 4,300 shares, signaling confidence as the company expands its insulin platform and seeks growth in Canada and the UK.

Talkspace CMO’s modest 12,148‑share sale amid a 30% weekly surge shows routine RSU liquidity, not a confidence shift—insiders stay bullish on AI‑driven growth.